Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to specific enzyme active sites, enhancing selectivity and potency. Commonly employed in medicinal chemistry for constructing bioactive molecules due to the stability and conformational rigidity provided by the cyclobutane ring. Also utilized in the preparation of analogs for structure-activity relationship (SAR) studies.